Pump Supplies denied as duplicate or overlapping therapy by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for pump supplies are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Issues a Duplicate-Therapy Denial for Pump Supplies

Blue Cross Blue Shield's duplicate-therapy denial for insulin pump supplies typically arises when the plan's system detects that a patient is receiving both pump supplies (reservoirs, infusion sets, sensors) and another diabetes supply category — most commonly insulin syringes or pens — within the same coverage period. BCBS's position is that a patient using a pump does not simultaneously need injection supplies for the same therapeutic purpose. However, this automated flag frequently produces incorrect denials: many patients legitimately need both (for example, backup injection supplies during pump failure, travel, or the transition between pump modalities).

These denials are highly appealable because the clinical record can almost always demonstrate a distinct, documented purpose for each supply category.

## Your Federal Appeal Rights

• Internal appeal: Under ACA §2719 and ERISA §503, BCBS must conduct a full clinical review and identify specifically which claim it considers duplicative and why.
• External review: Independent external review is available after internal exhaustion, typically within approximately four months of final denial.
• Expedited track: Given that insulin-delivery supply interruptions carry immediate safety risk, expedited review is appropriate and should be requested.

## Documentation to Gather

1. Prescriber letter — your physician or diabetes care team should explain the distinct clinical purpose of each supply category and why both are medically necessary. 2. Backup supply documentation — if pump supplies and injection supplies serve different roles (e.g., primary versus emergency/backup), document this explicitly with dates and clinical rationale. 3. Pump and therapy history — records showing when pump therapy was initiated, current pump model, and any documented pump failures or interruptions that required injection backup. 4. Applicable guideline reference — your physician may reference relevant American Diabetes Association (ADA) guidance on insulin delivery and backup supply management.

## Criteria-Mapping Structure

Request BCBS's written explanation of which specific claims it considers duplicative:

| BCBS Duplicate-Therapy Claim | Clinical Distinction and Supporting Evidence | |---|---| | [Paste the specific items BCBS flagged] | [Chart note documenting distinct purpose, date, and prescriber] |

## Next Step

Contact BCBS's DME or pharmacy benefit line before filing a formal appeal to confirm whether this is an automated claim-editing flag (which may be correctable with a modifier or clinical note) or a substantive coverage determination. Many duplicate-therapy denials for pump supplies are resolved through a clarifying letter from the prescriber without requiring full appeal escalation.